Caroline Almeida
Caroline Almeida is the head of public affairs at Gilead Sciences, a biopharmaceutical company known for its innovative treatments for HIV and other diseases. Almeida has been involved in discussions regarding the pricing and accessibility of lenacapavir, emphasizing the company's commitment to providing a not-for-profit price for this critical medication in low- and middle-income countries.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| South Africa | 1 | 6.00 | 0.51% | +0% | 59,308,690 | 302,595 | $350,000 | 1,786$ |
| Totals | 1 | 59,308,690 | 302,595 | $350,000 | 1,786$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
South Africa:
Caroline Almeida is Gilead’s head of public affairs discussing the pricing of lenacapavir.
6